0.4% Nitroglycerin ointment: In the treatment of chronic anal fissure pain

Drugs

Volumn 66, Issue 3, 2006, Pages 343-349

  Fenton, Caroline ^a   Wellington, Keri ^a   Easthope, Stephanie E ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; NITRIC OXIDE DONOR;

ANUS FISSURE; ANUS FISSURE PAIN; ANUS SPHINCTER; BURN; CLINICAL TRIAL; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; HEADACHE; HUMAN; NAUSEA; PAIN; PRURITUS; RECTUM DISEASE; RECTUM HEMORRHAGE; REVIEW; TACHYCARDIA; VISUAL ANALOG SCALE; VOMITING; CHRONIC DISEASE; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; OINTMENT; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; FISSURE IN ANO; HUMANS; NITRIC OXIDE DONORS; NITROGLYCERIN; OINTMENTS; PAIN; PAIN MEASUREMENT; RANDOMIZED CONTROLLED TRIALS;

EID: 33746097055     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200666030-00006     Document Type: Review

References (23)

1. Utzig MJ, Kroesen AJ, Buhr HJ. Concepts in pathogenesis and treatment of chronic anal fissure: a review of the literature. Am J Gastroenterol 2003 May; 98 (5): 968-74
2. Orsay C, Rakinic J, Perry WB, et al. Practice parameters for the management of anal fissures (revised). Dis Colon Rectum 2004 Dec; 47 (12): 2003-7
3. Schouten WR, Briel JW, Auwerda JJA. Relationship between anal pressure and anodermal blood flow: the vascular pathogenesis of anal fissures. Dis Colon Rectum 1994 Jul; 37 (7): 664-9
4. Bhardwaj R, Vaizey CJ, Boulos PB, et al. Neuromyogenic properties of the internal anal sphincter: therapeutic rationale for anal fissures. Gut 2000 Jun; 46 (6): 861-8
5. Lunc JN. Nitric oxide deficiency in the internal anal sphincter of patients with chronic anal fissure. Int J Colorectal Dis 2005 Jul 29 [Epub ahead of print]
6. Griffin N, Acheson AG, Tung P, et al. Quality of life in patients with chronic anal fissure. Colorectal Dis 2004; 6: 39-44
7. Lund JN, Royal S, Tierney GM, et al. Topical nitrate is an effective treatment for chronic anal fissure: a meta re-analysis [abstract no. P094]. European Association of Coloproctology/European Council of Coloproctology 2nd Joint Meeting; 2005 Sep 15-17; Bologna
8. Primary diagnosis and main operations for anal fissures in England. Cellegy Pharmaceuticals Inc., 2006. (Data on file)
9. Cellegy Pharmaceuticals Inc. Product information: Rectogesic™ (0.2% w/w Glyceryl Trinitate Ointment) [online]. Available from URL: http://www.rectogesic.com [Accessed 2006 Jan 16]
10. Azarnoff DL, Lee JC, Lee C, et al. A study to determine whether pharmacy extemporaneous compounding of nitroglycerin ointment provides a safe and effective treatment for anal fissures. Dis Colon Rectum. In Press
11. Cellegy Pharmaceuticals Inc. Summary of product characteristics: Rectogesic® 0.4% rectal ointment [online]. Available from URL: http://www.rectogesic.com [Accessed 2006 Jan 16]
12. Kua KB, Kocher HM, Kelkar A, et al. Effect of topical glyceryl trinitrate on anodermal blood flow in patients with chronic anal fissures. ANZ J Surg 2001 Sep; 71 (9): 548-50
13. Loder PB, Kamm MA, Nicholls RJ, et al. 'Reversible chemical sphincterotomy' by local application of glyceryl trinitrate. Br J Surg 1994 Sep; 81 (9): 1386-9
14. O'Kelly T, Brading A, Mortensen N. Nerve mediated relaxation of the human internal anal sphincter: the role of nitric oxide. Gut 1993 May; 34 (5): 689-93
15. Chakder S, Rattan S. Release of nitric oxide by activation of nonadrenergic noncholinergic neurons of internal anal sphincter. Am J Physiol 1993 Jan; 264 (1 Pt 1): G7-12
16. Ciccaglione AF, Grossi L, Cappello G, et al. Short- and long-term effect of glyceryl trinitrate (GTN) ointment 0.2% and 2% on anal canal pressure in patients with chronic anal fissures. Dig Dis Sci 2000 Dec; 45 (12): 2352-6
17. Bogaert MG. Clinical pharmacokinetics of glyceryl trinitrate following the use of systemic and topical preparations. Clin Pharmacokinet 1987 Jan; 12 (1): 1-11
18. Hashimoto S, Kobayashi A. Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites. Clin Pharmacokinet 2003; 42 (3): 205-21
19. Jonas M, Barrett DA, Shaw PN, et al. Systemic levels of glyceryl trinitrate following topical application to the anoderm do not correlate with the measured reduction in anal pressure. Br J Surg 2001 Dec; 88 (12): 1613-6
20. Bailey HR, Beck DE, Billingham RP, et al. A study to determine the nitroglycerin ointment dose and dosing interval that best promote the healing of chronic anal fissures. Dis Colon Rectum 2002 Sep; 45 (9): 1192-9
21. Sands L. and the Glyceryl Trinitrate Anal Fissure Study Group. Pain relief from 0.2% and 0.4% glyceryl trinitrate in patients with chronic anal fissure [abstract]. European Association of Coloproctology/European Council of Coloproctology 2nd Joint Meeting; 2005 Sep 15-17; Bologna
22. CP 125 03-02-01. Cellegy Pharmaceuticals Inc., 2005. (Data on file)
23. Scholefield JH, Bock JU, Marla B, et al. A dose finding study with 0.1%, 0.2%, and 0.4% glyceryl trinitrate ointment in patients with chronic anal fissures. Gut 2003 Feb; 52 (2): 264-9